Article Information
vol. 8 no. 2
Published By
Online ISSN
History
- Received December 2, 2021
- Accepted March 4, 2022
- Published online May 3, 2022.
Article Versions
- previous version (April 21, 2022 - 08:27).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This article is open access and distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Marlies Wijsenbeek1⇑,
- Maria Molina-Molina2,
- Olivier Chassany3,4,
- John Fox5,
- Liam Galvin6,
- Klaus Geissler7,
- Katherine M. Hammitt8,
- Michael Kreuter9,
- Teng Moua10,
- Emily C. O'Brien11,
- Ashley F. Slagle12,
- Anna Krasnow13,
- Matthew Reaney14,
- Michael Baldwin15,
- Natalia Male15,
- Klaus B. Rohr15,
- Jeff Swigris16 and
- Katerina Antoniou17
- 1Dept of Respiratory Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands
- 2Dept of Pneumology, Unit of Interstitial Lung Diseases, University Hospital of Bellvitge, Institute for Biomedical Research (IDIBELL), Barcelona, Spain
- 3Patient-Reported Outcomes Research Unit, Université de Paris, Paris, France
- 4Health Economics Clinical Trial Unit (URC-ECO), Hotel-Dieu Hospital, AP-HP, Paris, France
- 5Foxworthy Healthcare Consulting, Ada, MI, USA
- 6European Idiopathic Pulmonary Fibrosis and Related Disorders Federation, Overijse, Belgium
- 7Patient Support Group, Lungenfibrose eV, Essen, Germany
- 8Sjögren's Foundation, Reston, VA, USA
- 9Center for Interstitial and Rare Lung Diseases, Department of Pneumology, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany
- 10Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA
- 11Duke Clinical Research Institute, Durham, NC, USA
- 12Aspen Consulting, LLC, Steamboat Springs, CO, USA
- 13Patient Centred Solutions, IQVIA, London, UK
- 14Patient Centred Solutions, IQVIA, Reading, UK
- 15Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
- 16National Jewish Health, Denver, CO, USA
- 17Laboratory of Cellular and Molecular Pneumonology, Dept of Respiratory Medicine, School of Medicine, University of Crete, Crete, Greece
- Corresponding author: Marlies Wijsenbeek (m.wijsenbeek-lourens{at}erasmusmc.nl)
Funding
Boehringer Ingelheim
N/A
Article usage
Altmetrics
Vol 8 Issue 2
Table of Contents
Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures
